Indivior Pharmaceuticals, Inc. INDV Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $175M-53.0% | $195M-38.9% | $445M+54.5% | $510M+68.9% | $372M+50.0% | ||
| $273M+12.3% | $253M-0.4% | $259M+2,978% | $240M+2,300% | $243M+6,175% | ||
| $1M-91.7% | $2M-80.0% | $1M-83.3% | $17M+113% | $12M-55.6% | ||
| $667M-24.5% | $652M-21.2% | $922M— | $951M— | $883M— | ||
| $157M+51.0% | $144M+44.0% | $124M— | $117M— | $104M— | ||
| $2M-71.4% | $2M-66.7% | $2M— | $7M— | $7M— | ||
| $1.2B-12.9% | $1.2B-8.7% | $1.42B— | $1.45B— | $1.38B— | ||
| $35M-23.9% | $48M-23.8% | $41M— | $50M— | $46M— | ||
| $0-100% | $29M+61.1% | $18M— | $18M— | $18M— | ||
| $779M-22.5% | $914M-1.1% | $965M— | $1.06B— | $1.01B— | ||
| $486M+56.3% | $290M-7.9% | $304M— | $308M— | $311M— | ||
| $1.34B-19.2% | $1.3B-21.3% | $1.62B— | $1.71B— | $1.66B— | ||
| $0-100% | $62M0.0% | $62M— | $62M— | $62M— | ||
| -$280M+31.0% | -$243M+45.1% | -$346M— | -$388M— | -$406M— | ||
| -$144M+49.5% | -$98M+70.9% | -$207M+33.2% | -$257M+8.5% | -$285M-77.0% | ||
| $1.2B-12.9% | $1.2B-8.7% | $1.42B— | $1.45B— | $1.38B— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Indivior Pharmaceuticals, Inc. 's total assets?
- Indivior Pharmaceuticals, Inc. (INDV) holds $1.2B in total assets, down 13.0% year over year.
- How much debt does Indivior Pharmaceuticals, Inc. have?
- Indivior Pharmaceuticals, Inc. carries $509.0M in total debt against -$144.0M of shareholders' equity, a debt-to-equity ratio of -3.53.
- How much cash does Indivior Pharmaceuticals, Inc. have?
- Indivior Pharmaceuticals, Inc. holds $175.0M in cash and equivalents.
- Can Indivior Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 0.86 — current liabilities exceed current assets.
- Where does Indivior Pharmaceuticals, Inc. 's balance sheet data come from?
- Every line is extracted from Indivior Pharmaceuticals, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
